Clorox

-12.53%

Clorox has fallen to around $80, near its 52-week low of $79.12 and dramatically below its $128.90 high. That collapse has pushed the valuation into territory that could interest value investors, but the real question is whether the market is pricing in temporary problems or permanently weaker profitability. Fiscal 2026 was difficult. Revenue declined 5% to $6.72 billion, while gross margin fell from 45.2% to 42.3%. Diluted earnings per share dropped 26% to $4.81. The completed $2.25 billion GOJO acquisition adds growth potential, but integration costs and debt are creating additional pressure. Management expects fiscal 2027 sales to increase 13% to 14%, with adjusted earnings per share of $5.70 to $6.00. However, gross margin is expected to remain around 42%, showing that inflation and unfavorable product mix are still significant obstacles. The dividend remains a major attraction. The quarterly payment increased from $1.20 in 2024 to $1.22 in 2025 and $1.25 in 2026, or $5.00 annually at the latest rate. For value investors, the appeal is the depressed price, strong brands and potential GOJO synergies. The risks are weak volumes, margin pressure, debt and slow recovery. A sustained recovery may require improving margins and stronger earnings. This review is for informational and educational purposes only, not financial advice.

Clorox shares have declined and now trade well below recent highs, raising a key question for investors: is this a temporary disruption or a deeper shift? The stock has come under pressure following weaker results, with revenue slightly declining and earnings falling more sharply. Margins have compressed due to higher costs and a significant inventory correction at retailers. Free cash flow remains solid, and the company continues to support a long history of dividend growth, although recent increases have been modest. Profitability, while still healthy, is below prior peak levels. Management is focused on restoring volumes and stabilizing margins over time. The stock is down mainly due to declining sales, margin pressure, and inventory adjustments. A recovery depends on demand normalization and improved cost control. This review is for informational and educational purposes only, not financial advice.

Clorox stock is down despite iconic brands and steady demand. A fast, educational look at fundamentals, risks and recovery potential in under one minute.

Explore why Clorox stock is down, understand its business, recent financial performance, dividend history, risks, and potential opportunities for long-term investors in consumer goods.

An analysis of Clorox’s financial performance, dividend history, and investment considerations for value investors

Clorox stock is under pressure after recent earnings and a major cyberattack. But with a strong brand portfolio and recovering margins, could this be a rare opportunity to buy a defensive dividend grower on sale? Watch our full analysis and visit InsightfulValue.com for more value investing insights.